ImmunoGen Inc.
-
Ticker
IMGN
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 201-500 Employees
- Based in Waltham, Massachusetts
ImmunoGen, Inc. engages in the research and development of antibody-based anticancer therapeutics in the United States. The company develops its product candidates using its Targeted Antibody Payload (TAP) technology.
ImmunoGen Inc.
Most Recent Responsibility Report
Our service enables potential investors to review the most recent and archived ImmunoGen Inc. Sustainability Report, ImmunoGen Inc. Corporate Social Responsibility Report, ImmunoGen Inc. CSR Report, ImmunoGen Inc. Corporate Responsibility, ImmunoGen Inc. CR Report, ImmunoGen Inc. Citizenship Report, ImmunoGen Inc. ESG Report, and ImmunoGen Inc. Environmental Report online.